Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient

J Gastroenterol Hepatol. 2012 Jan;27(1):137-41. doi: 10.1111/j.1440-1746.2011.06835.x.

Abstract

Background and aims: Balloon-occluded retrograde transvenous obliteration (B-RTO) is an effective treatment for gastric varices (GVx), as well as hepatic encephalopathy. The aim of this study was to examine the changes of the hepatic vein pressure gradient (HVPG) after B-RTO and determine the relation between the changes of HVPG and liver function.

Patients and methods: B-RTO was performed in 30 patients with GVx and hepatic encephalopathy. HVPG was measured in 19 of 30 patients both before and after B-RTO.

Results: The B-RTO was successful in all patients. The GVx and hepatic encephalopathy were improved, and no recurrence or bleeding was observed within the follow- up period. The serum albumin and prothrombin activity were significantly improved 6 months after B-RTO in all patients. HVPG was elevated 44% above the baseline after B-RTO. Liver function significantly improved 6 months after B-RTO in patients whose HVPG increased ≥ 20% from baseline.

Conclusion: An elevated HVPG after B-RTO is one aspect of the effect of liver function, and an HVPG increase of ≥ 20% from baseline is a predictive factor for obtaining an improvement of liver function.

MeSH terms

  • Aged
  • Balloon Occlusion* / adverse effects
  • Biomarkers / blood
  • Esophageal and Gastric Varices / blood
  • Esophageal and Gastric Varices / diagnosis
  • Esophageal and Gastric Varices / physiopathology
  • Esophageal and Gastric Varices / therapy*
  • Female
  • Hepatic Encephalopathy / blood
  • Hepatic Encephalopathy / diagnosis
  • Hepatic Encephalopathy / physiopathology
  • Hepatic Encephalopathy / therapy*
  • Hepatic Veins / physiopathology*
  • Humans
  • Japan
  • Liver / blood supply*
  • Liver / metabolism
  • Liver / physiopathology*
  • Liver Function Tests
  • Male
  • Middle Aged
  • Oleic Acids / administration & dosage
  • Prothrombin / metabolism
  • Recovery of Function
  • Sclerosing Solutions / administration & dosage
  • Sclerotherapy* / adverse effects
  • Serum Albumin / metabolism
  • Time Factors
  • Treatment Outcome
  • Venous Pressure

Substances

  • Biomarkers
  • Oleic Acids
  • Sclerosing Solutions
  • Serum Albumin
  • Prothrombin
  • ethanolamine oleate